Begor Mark W — SEC insider filings
SEC reporting owner CIK 1335111. 57 insider filings on record with FilingPulse; latest filed 2026-10-27.
Transaction summary — filings shown
Covers the 50 most recent of 57 filings on record, filed 2021-10-04 to 2026-10-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 98 legs across 17 filings — 573,299 shares, $131,061,034 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 80.
- Largest priced transaction: sale of 35,040 shares @ $267.94 ($9,388,779) in EQUIFAX INC, filed 2024-02-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EQUIFAX INC (EFX) | CEO, Director | 30 | — | 98 legs · 573,299 sh · $131,061,034 | 59 |
| NCR CORP (NCR) | Director | 11 | — | — | 11 |
| NCR Atleos Corp (NATL) | Director | 7 | — | — | 8 |
| RAYMOND JAMES FINANCIAL INC (RJF) | Director | 2 | — | — | 2 |
Insider filings — Begor Mark W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-27 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 37,792 @ $112.46 · Sale (S): 1,194 @ $186.73 · Sale (S): 1,250 @ $183.40 · Sale (S): 1,681 @ $185.20 · Sale (S): 33,667 @ $182.52 · Option exercise (M): 37,792 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 37,791 @ $112.46 · Sale (S): 500 @ $175.85 · Sale (S): 600 @ $169.86 · Sale (S): 600 @ $168.47 · Sale (S): 1,300 @ $174.91 · Sale (S): 2,936 @ $173.79 · +4 more | EDGAR |
| 2026-04-28 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 37,791 @ $112.46 · Sale (S): 1,717 @ $174.32 · Sale (S): 4,659 @ $173.39 · Sale (S): 10,944 @ $171.57 · Sale (S): 20,471 @ $172.46 · Option exercise (M): 37,791 (derivative) @ $112.46 | EDGAR |
| 2026-02-27 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 40,955 @ $0 | EDGAR |
| 2026-02-23 | 4 | RAYMOND JAMES FINANCIAL INC (RJF) | Grant/award (A): 1,303 @ $0 | EDGAR |
| 2026-02-12 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 37,791 @ $112.46 · Grant/award (A): 33,278 @ $0 · Sale (S): 201 @ $197.79 · Sale (S): 213 @ $203.76 · Sale (S): 227 @ $192.89 · Sale (S): 331 @ $194.22 · +9 more | EDGAR |
| 2026-02-05 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 59,123 @ $0 · Tax withholding (F): 2,405 @ $175.05 | EDGAR |
| 2026-01-05 | 4 | EQUIFAX INC (EFX) | Tax withholding (F): 997 @ $216.98 | EDGAR |
| 2025-10-29 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 27,959 @ $191.44 · Gift (G): 47 @ $0 · Sale (S): 174 @ $233.88 · Sale (S): 204 @ $235.22 · Sale (S): 3,757 @ $231.46 · Sale (S): 4,015 @ $233.01 · +11 more | EDGAR |
| 2025-07-30 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 27,960 @ $191.44 · Sale (S): 364 @ $244.95 · Sale (S): 831 @ $243.90 · Sale (S): 9,497 @ $242.70 · Sale (S): 17,731 @ $241.87 · Sale (S): 19,841 @ $240.95 · +1 more | EDGAR |
| 2025-05-23 | 4 | RAYMOND JAMES FINANCIAL INC (RJF) | Grant/award (A): 982 @ $0 | EDGAR |
| 2025-05-23 | 4 | NCR Atleos Corp (NATL) | Option exercise (M): 2,690 @ $25.98 | EDGAR |
| 2025-04-30 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 22,160 @ $175.48 · Sale (S): 22,160 @ $256.61 · Option exercise (M): 22,160 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | NCR Atleos Corp (NATL) | Grant/award (A): 996 (derivative) @ $26.38 | EDGAR |
| 2025-02-18 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 22,161 @ $175.48 · Sale (S): 595 @ $253.60 · Sale (S): 1,402 @ $256.31 · Sale (S): 1,600 @ $252.38 · Sale (S): 5,214 @ $255.27 · Sale (S): 6,199 @ $250.74 · +2 more | EDGAR |
| 2025-02-13 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 20,527 @ $0 · Tax withholding (F): 1,213 @ $253 | EDGAR |
| 2025-02-12 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 13,524 @ $0 · Grant/award (A): 23,519 (derivative) @ $0 · Grant/award (A): 21,668 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | NCR Atleos Corp (NATL) | Grant/award (A): 774 (derivative) @ $33.92 | EDGAR |
| 2024-10-29 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 58,304 @ $149.53 · Sale (S): 6,900 @ $271.68 · Sale (S): 7,703 @ $272.32 · Sale (S): 21,447 @ $269.49 · Sale (S): 22,254 @ $270.45 · Option exercise (M): 58,304 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | NCR Atleos Corp (NATL) | Grant/award (A): 920 (derivative) @ $28.53 | EDGAR |
| 2024-07-30 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 34,408 @ $149.53 · Option exercise (M): 23,892 @ $138.45 · Sale (S): 4,204 @ $271.04 · Sale (S): 5,671 @ $267.54 · Sale (S): 7,958 @ $268.04 · Sale (S): 17,594 @ $269.38 · +3 more | EDGAR |
| 2024-07-25 | 4 | EQUIFAX INC (EFX) | Gift (G): 1,853 @ $0 | EDGAR |
| 2024-07-02 | 4 | NCR Atleos Corp (NATL) | Grant/award (A): 971 (derivative) @ $27.02 | EDGAR |
| 2024-05-23 | 4 | NCR Atleos Corp (NATL) | Grant/award (A): 5,686 @ $28.14 | EDGAR |
| 2024-04-30 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 53,003 @ $138.45 · Option exercise (M): 5,297 @ $127.37 · Sale (S): 3,129 @ $227.06 · Sale (S): 18,907 @ $225.88 · Sale (S): 36,264 @ $225.08 · Option exercise (M): 5,297 (derivative) @ $127.37 · +1 more | EDGAR |
| 2024-02-29 | 4 | EQUIFAX INC (EFX) | Option exercise (M): 58,300 @ $127.37 · Sale (S): 990 @ $264.97 · Sale (S): 1,939 @ $265.99 · Sale (S): 2,008 @ $268.58 · Sale (S): 18,323 @ $266.88 · Sale (S): 35,040 @ $267.94 · +1 more | EDGAR |
| 2024-02-14 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 39,822 @ $0 · Tax withholding (F): 2,114 @ $255.78 | EDGAR |
| 2024-02-13 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 8,107 @ $0 · Grant/award (A): 15,662 (derivative) @ $0 · Grant/award (A): 14,097 (derivative) @ $0 | EDGAR |
| 2023-11-02 | 4 | EQUIFAX INC (EFX) | Sale (S): 88 @ $168.88 · Sale (S): 1,482 @ $166.92 · Sale (S): 1,504 @ $165.07 · Sale (S): 1,872 @ $168.39 · Sale (S): 2,054 @ $165.68 | EDGAR |
| 2023-10-18 | 4 | NCR Atleos Corp (NATL) | Grant/award (A): 18,257 · Grant/award (A): 8,318 (derivative) | EDGAR |
| 2023-10-03 | 4 | NCR CORP (NCR) | Grant/award (A): 951 (derivative) @ $26.97 | EDGAR |
| 2023-08-04 | 4 | EQUIFAX INC (EFX) | Sale (S): 473 @ $200.32 · Sale (S): 787 @ $202.11 · Sale (S): 5,740 @ $201.37 | EDGAR |
| 2023-07-05 | 4 | NCR CORP (NCR) | Grant/award (A): 1,017 (derivative) @ $25.20 | EDGAR |
| 2023-05-22 | 4 | EQUIFAX INC (EFX) | Sale (S): 650 @ $207.62 · Sale (S): 808 @ $206.22 · Sale (S): 1,526 @ $209.49 · Sale (S): 4,016 @ $208.49 | EDGAR |
| 2023-05-04 | 4 | NCR CORP (NCR) | Grant/award (A): 10,761 @ $20.91 | EDGAR |
| 2023-04-04 | 4 | NCR CORP (NCR) | Grant/award (A): 1,087 (derivative) @ $23.59 | EDGAR |
| 2023-02-23 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 30,816 @ $0 · Tax withholding (F): 19,764 @ $203.81 | EDGAR |
| 2023-02-14 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 9,799 @ $0 · Grant/award (A): 18,346 (derivative) @ $0 · Grant/award (A): 16,580 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | NCR CORP (NCR) | Grant/award (A): 1,400 (derivative) @ $23.41 | EDGAR |
| 2022-10-28 | 4 | EQUIFAX INC (EFX) | Sale (S): 380 @ $163.45 · Sale (S): 640 @ $167.66 · Sale (S): 713 @ $162.19 · Sale (S): 2,394 @ $165.58 · Sale (S): 3,148 @ $166.98 · Sale (S): 3,725 @ $164.71 | EDGAR |
| 2022-10-03 | 4 | NCR CORP (NCR) | Grant/award (A): 2,335 (derivative) @ $19.01 | EDGAR |
| 2022-08-02 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 23,934 @ $0 · Grant/award (A): 48,281 (derivative) @ $0 · Grant/award (A): 43,440 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4 | NCR CORP (NCR) | Grant/award (A): 1,427 (derivative) @ $31.11 | EDGAR |
| 2022-05-04 | 4 | NCR CORP (NCR) | Grant/award (A): 6,479 @ $34.73 | EDGAR |
| 2022-04-28 | 4 | EQUIFAX INC (EFX) | Sale (S): 429 @ $200.78 · Sale (S): 490 @ $207.71 · Sale (S): 741 @ $208.73 · Sale (S): 992 @ $206.87 · Sale (S): 995 @ $209.73 · Sale (S): 1,150 @ $201.68 · +4 more | EDGAR |
| 2022-04-01 | 4 | NCR CORP (NCR) | Grant/award (A): 1,105 (derivative) @ $40.19 | EDGAR |
| 2022-02-24 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 86,818 @ $0 · Tax withholding (F): 46,485 @ $212.24 | EDGAR |
| 2022-02-15 | 4 | EQUIFAX INC (EFX) | Grant/award (A): 8,978 @ $0 · Grant/award (A): 19,649 (derivative) @ $0 · Grant/award (A): 17,522 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | NCR CORP (NCR) | Grant/award (A): 1,104 (derivative) @ $40.20 | EDGAR |
| 2021-10-04 | 4 | NCR CORP (NCR) | Grant/award (A): 1,145 (derivative) @ $38.76 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1335111 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs